249 related articles for article (PubMed ID: 29635432)
1. Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients.
Gardiner BJ; Nierenberg NE; Chow JK; Ruthazer R; Kent DM; Snydman DR
Clin Infect Dis; 2018 Oct; 67(9):1395-1402. PubMed ID: 29635432
[TBL] [Abstract][Full Text] [Related]
2. The impact of recurrent cytomegalovirus infection on long-term survival in solid organ transplant recipients.
Gardiner BJ; Chow JK; Brilleman SL; Peleg AY; Snydman DR
Transpl Infect Dis; 2019 Dec; 21(6):e13189. PubMed ID: 31581352
[TBL] [Abstract][Full Text] [Related]
3. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
[TBL] [Abstract][Full Text] [Related]
4. Post-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation.
Yoon M; Oh J; Chun KH; Lee CJ; Kang SM
Sci Rep; 2021 Jan; 11(1):1426. PubMed ID: 33446808
[TBL] [Abstract][Full Text] [Related]
5. Absolute Lymphocyte Count as a Marker for Cytomegalovirus Infection After Heart Transplantation.
Schoeberl AK; Zuckermann A; Kaider A; Aliabadi-Zuckermann A; Uyanik-Uenal K; Laufer G; Goekler J
Transplantation; 2023 Mar; 107(3):748-752. PubMed ID: 36228318
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with the development of cytomegalovirus infection following solid organ transplantation.
da Cunha-Bang C; Sørensen SS; Iversen M; Sengeløv H; Hillingsø JG; Rasmussen A; Mortensen SA; Fox ZV; Kirkby NS; Christiansen CB; Lundgren JD
Scand J Infect Dis; 2011 May; 43(5):360-5. PubMed ID: 21306196
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of CMV Infection and the Effect of Prolonged Antivirals in Organ Transplant Recipients.
Natori Y; Humar A; Husain S; Rotstein C; Renner E; Singer L; Kim SJ; Kumar D
Transplantation; 2017 Jun; 101(6):1449-1454. PubMed ID: 27467535
[TBL] [Abstract][Full Text] [Related]
8. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment.
Fernández-Ruiz M; Giménez E; Vinuesa V; Ruiz-Merlo T; Parra P; Amat P; Montejo M; Paez-Vega A; Cantisán S; Torre-Cisneros J; Fortún J; Andrés A; San Juan R; López-Medrano F; Navarro D; Aguado JM;
Clin Microbiol Infect; 2019 Mar; 25(3):381.e1-381.e10. PubMed ID: 29803844
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients.
Freeman RB; Paya C; Pescovitz MD; Humar A; Dominguez E; Washburn K; Blumberg E; Alexander B; Heaton N;
Transplantation; 2004 Dec; 78(12):1765-73. PubMed ID: 15614149
[TBL] [Abstract][Full Text] [Related]
10. Association Between Lymphopenia at 1 Month Posttransplant and Infectious Outcomes or Death in Heart Transplant Recipients.
Perry WA; Paulus JK; Price LL; Snydman DR; Chow JK
Clin Infect Dis; 2021 Dec; 73(11):e3797-e3803. PubMed ID: 33279963
[TBL] [Abstract][Full Text] [Related]
11. Relapsing cytomegalovirus infection in solid organ transplant recipients.
Shanahan A; Malani PN; Kaul DR
Transpl Infect Dis; 2009 Dec; 11(6):513-8. PubMed ID: 19735385
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an electronic, patient-focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation.
Ekenberg C; da Cunha-Bang C; Lodding IP; Sørensen SS; Sengeløv H; Perch M; Rasmussen A; Gustafsson F; Wareham NE; Kirkby N; Kjaer J; Helleberg M; Reekie J; Lundgren JD
Transpl Infect Dis; 2020 Apr; 22(2):e13252. PubMed ID: 31997565
[TBL] [Abstract][Full Text] [Related]
13. Clinical Correlation of Cytomegalovirus Infection With CMV-specific CD8+ T-cell Immune Competence Score and Lymphocyte Subsets in Solid Organ Transplant Recipients.
Meesing A; Abraham RS; Razonable RR
Transplantation; 2019 Apr; 103(4):832-838. PubMed ID: 30086091
[TBL] [Abstract][Full Text] [Related]
14. Impact of pretransplant CMV-specific T-cell immune response in the control of CMV infection after solid organ transplantation: a prospective cohort study.
Molina-Ortega A; Martín-Gandul C; Mena-Romo JD; Rodríguez-Hernández MJ; Suñer M; Bernal C; Sánchez M; Sánchez-Céspedes J; Pérez Romero P; Cordero E
Clin Microbiol Infect; 2019 Jun; 25(6):753-758. PubMed ID: 30292792
[TBL] [Abstract][Full Text] [Related]
15. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
16. Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime?
Melendez D; Razonable RR
Expert Rev Clin Immunol; 2014 Sep; 10(9):1213-27. PubMed ID: 25081073
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
18. Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
Young PG; Rubin J; Angarone M; Flaherty J; Penugonda S; Stosor V; Ison MG
Transpl Infect Dis; 2016 Jun; 18(3):390-5. PubMed ID: 27037651
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus myocarditis in solid organ transplant recipients: A case series and review of literature.
Scherger S; Mathur S; Bajrovic V; Johnson SC; Benamu E; Ramanan P; Wolfel G; Levi ME; Abidi MZ
Transpl Infect Dis; 2020 Jun; 22(3):e13282. PubMed ID: 32232951
[TBL] [Abstract][Full Text] [Related]
20. Use of maintenance therapy and incidence of recurrent Cytomegalovirus DNAemia among allogeneic hematopoietic cell transplant recipients.
Camargo JF; Anderson AD; Rosa R; Kimble E; Komanduri KV; Morris MI
Transpl Infect Dis; 2019 Apr; 21(2):e13054. PubMed ID: 30689300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
